Navigation Links
Max Neeman International Initiates Advisory Committee to Advance and Improve the Conduct of Complex Neurological Trials in India
Date:2/14/2011

RESEARCH TRIANGLE PARK, N.C., Feb. 14, 2011 /PRNewswire/ -- India's premier CRO, Max Neeman, participated in the 59th annual Neurological Society of India & Congress of Neurological Surgeons (NEUROCON) held in Jaipur, India this past December.  The event was a convergence of leading neuroscientists, neurosurgeons, neurologists, physicians, surgeons, biotechnologists and researchers from across the globe to discuss advances made in the area of Neurology & Neurosurgery.

(Logo: http://photos.prnewswire.com/prnh/20110105/CL25129LOGO)

Max Neeman brought together USA and India based renowned group of Neuro and Spinal surgeons from prestigious hospitals across India and USA to form an advisory committee.

The Advisory Committee is to develop strategies for clinical research across newer therapies for central nervous system disorders.  Regulatory challenges and technical issues along with associated strategies of conducting the clinical trials of newer therapies in India were planned.

Max Neeman has conducted approximately 10% surgical intervention trials to date of over 230 trials awarded.  As part of the Max India Group, Max Neeman collaborates with 'Max Healthcare's' top physicians and neurosurgeons across India including Neurosciences departments, and one dedicated Neurological Institute, as part of the [8] hospital group; Max Healthcare.

About Max Neeman International

Max Neeman International is one of the leading and largest CROs in India and the clinical research arm of healthcare conglomerate, Max India.  Our specialty is that we offer services for the successful conduct of Phase I-IV clinical and device trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2008 certified CRO for Monitoring, Site Management and Data Management Services. The company has 6 regional offices and 175 sites across 31 cities. Contact Donald Swankie, Vice President USA via email to donald.swankie@neeman-medical.com or call +1.919.424.3345.  www.neeman-medical.com

About Max Healthcare

Also part of the Max India group, Max Healthcare is part of a leading chain of hospitals in India.  Its state of the art infrastructure, top-notch physicians, and most advanced technologies makes it one of the best hospitals in the country. www.maxhealthcare.in


'/>"/>
SOURCE Max Neeman International
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Indias Favorable and Progressive Regulatory Environment Causes Accelerated Growth of Max Neeman Internationals Regulatory Services
2. Max Neeman International Signs Agreement for Data Management/EDC of Large Phase IV Trials from Multiple Sites
3. Max Neeman International to Open Phase I/IIa Unit
4. International Isotopes Inc. Announces a Shareholder Conference Call for February 7, 2011
5. Bacterin International Holdings Secures $5,000,000 Credit Facility with Bridge Bank
6. 4th International Conference on Electrophoretic Deposition
7. Verenium Announces Favorable Outcome of Capital Ventures International Lawsuit
8. Cellular Dynamics International to Present at 29th Annual JPMorgan Healthcare Conference
9. Halt Medical Presents Strong Results of International Fibroid Studies at National Institutes of Health Global Congress
10. Web of international collaboration boosts worldwide nanotechnology research
11. ViroPharma Incorporated and Idis Partner to Facilitate International Access to Certain ViroPharma Therapeutics Through Named Patient Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
Breaking Biology Technology:
(Date:5/20/2016)... May 20, 2016  VoiceIt is excited to ... VoicePass. By working together, VoiceIt and ... VoiceIt and VoicePass take slightly different approaches to ... both security and usability. ... this new partnership. "This marketing and ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
Breaking Biology News(10 mins):